MEK inhibition causes BIM stabilization and increased sensitivity to BCL-2 family member inhibitors in RAS-MAPK-mutated neuroblastoma
Eleveld, Thomas F, Vernooij, Lindy, Schild, Linda, Koopmans, Bianca, Alles, Lindy K, Ebus, Marli E, Dandis, Rana, van Tinteren, Harm, Caron, Huib N, Koster, Jan, van Noesel, Max M, Tytgat, Godelieve A M, Eising, Selma, Versteeg, Rogier, Dolman, M Emmy M, Molenaar, Jan J
Published in Frontiers in oncology (21.02.2023)
Published in Frontiers in oncology (21.02.2023)
Get full text
Journal Article
Preclinical assessment of combined BCL-2 and MCL-1 inhibition in high-risk neuroblastoma
Vernooij, Lindy, Kamili, Alvin, Ober, Kimberley, van Arkel, Jennemiek, Lankhorst, Lina, Vermeulen, Enya, Al-Khakany, Hanin, Tax, Gabor, van den Boogaard, Marlinde L., Fletcher, Jamie I., Eising, Selma, Molenaar, Jan J., Dolman, M. Emmy M.
Published in EJC paediatric oncology (01.06.2024)
Published in EJC paediatric oncology (01.06.2024)
Get full text
Journal Article
Abstract A49: Combined targeting of the p53 and pRb pathway in neuroblastoma
Schubert, Nil, Schild, Linda, van Oirschot, Stijn, Keller, Kaylee, Alles, Lindy, Vernooij, Lindy, Nulle, Marloes, Dolman, Emmy, van den Boogaard, Marlinde, Molenaar, Jan
Published in Cancer research (Chicago, Ill.) (15.07.2020)
Published in Cancer research (Chicago, Ill.) (15.07.2020)
Get full text
Journal Article
Combined targeting of the p53 and pRb pathway in neuroblastoma does not lead to synergistic responses
Schubert, Nil A., Schild, Linda, van Oirschot, Stijn, Keller, Kaylee M., Alles, Lindy K., Vernooij, Lindy, Nulle, Marloes E., Dolman, M. Emmy M., van den Boogaard, Marlinde L., Molenaar, Jan J.
Published in European journal of cancer (1990) (01.01.2021)
Published in European journal of cancer (1990) (01.01.2021)
Get full text
Journal Article
High-Throughput Screening Identifies Idasanutlin as a Resensitizing Drug for Venetoclax-Resistant Neuroblastoma Cells
Vernooij, Lindy, Bate-Eya, Laurel T, Alles, Lindy K, Lee, Jasmine Y, Koopmans, Bianca, Jonus, Hunter C, Schubert, Nil A, Schild, Linda, Lelieveld, Daphne, Egan, David A, Kerstjens, Mark, Stam, Ronald W, Koster, Jan, Goldsmith, Kelly C, Molenaar, Jan J, Dolman, M Emmy M
Published in Molecular cancer therapeutics (01.06.2021)
Published in Molecular cancer therapeutics (01.06.2021)
Get full text
Journal Article
Abstract B021: Enhancing clinical decision-making: The role of ex vivo drug sensitivity profiling in pediatric precision medicine
Schoonbeek, Marlinde C., Vernooij, Lindy, Swaak, Sarah E.M., Amo-Addae, Vicky J.E., Koster, Jan, Van Hooff, Sander, Eising, Selma, Van den Boogaard, Marlinde T.L., Molenaar, Jan J.
Published in Cancer research (Chicago, Ill.) (05.09.2024)
Published in Cancer research (Chicago, Ill.) (05.09.2024)
Get full text
Journal Article
Abstract 2630: Preclinical identification of Venetoclax combination strategies with Idasanutlin, CUDC-907, Prexasertib or Talazoparib for neuroblastoma treatment
Dolman, M. Emmy M., Bate-Eya, Laurel T., Vernooij, Lindy, Koopmans, Bianca, Alles, Lindy K., Essing, Anke H., Lelieveld, Daphne, Egan, David A., Kerstjens, Mark, Stam, Ronald W., Caron, Huib N., Molenaar, Jan J.
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Get full text
Journal Article
MEK inhibition causes Bim stabilization and sensitivity to Bcl2 family member inhibitors in RAS-MAPK mutated neuroblastoma
Eleveld, Thomas F, Vernooij, Lindy, Schild, Linda, Koopmans, Bianca, Alles, Lindy K, Ebus, Marli E, Van Sluis, Peter G, Caron, Huib N, Koster, Jan, Versteeg, Rogier, Dolman, Emmy M, Molenaar, Jan J
Published in bioRxiv (07.03.2020)
Published in bioRxiv (07.03.2020)
Get full text
Paper